Literature DB >> 17406976

Angiotensin receptor type 1 blockade in astroglia decreases hypoxia-induced cell damage and TNF alpha release.

Lusine Danielyan1, Ali Lourhmati, Stephan Verleysdonk, Daniela Kabisch, Barbara Proksch, Ulrike Thiess, Sumaira Umbreen, Boris Schmidt, Christoph H Gleiter.   

Abstract

The present study investigated the role of angiotensin receptors (AT-R) in the survival and inflammatory response of astroglia upon hypoxic injury. Exposure of rat astroglial primary cultures (APC) to hypoxic conditions (HC) led to decreased viability of the cells and to a 3.5-fold increase in TNF-alpha release. AT-R type1 (AT1-R) antagonist losartan and its metabolite EXP3174 decrease the LDH release (by 36 +/- 9%; 45 +/- 6%) from APC under HC. Losartan diminished TNF-alpha release (by 40 +/- 15%) and the number of TUNEL-cells by 204 +/- 38% under HC, alone and together with angiotensin II (ATII), while EXP3174 was dependent on ATII for its effect on TNF-alpha. The AT2-R antagonist, PD123.319, did not influence the release of LDH and TNF-alpha under normoxic (NC) and HC. These data suggest that AT1-R may decrease the susceptibility of astrocytes to hypoxic injury and their propensity to release TNF-alpha. AT1-R antagonists may therefore be of therapeutic value during hypoxia-associated neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406976     DOI: 10.1007/s11064-007-9337-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  45 in total

1.  Regulation of peroxisome proliferator-activated receptor gamma activity by losartan metabolites.

Authors:  Michael Schupp; Lucas D Lee; Nikolaj Frost; Sumaira Umbreen; Boris Schmidt; Thomas Unger; Ulrich Kintscher
Journal:  Hypertension       Date:  2005-12-19       Impact factor: 10.190

2.  Distinct expressions of three cytokines by IL-1-stimulated astrocytes in vitro and in AIDS brain.

Authors:  L Vitkovic; J J Chatham; A da Cunha
Journal:  Brain Behav Immun       Date:  1995-12       Impact factor: 7.217

3.  IL-17 and IFN-gamma mRNA expression is increased in the brain and systemically after permanent middle cerebral artery occlusion in the rat.

Authors:  H L Li; N Kostulas; Y M Huang; B G Xiao; P van der Meide; V Kostulas; V Giedraitas; H Link
Journal:  J Neuroimmunol       Date:  2001-05-01       Impact factor: 3.478

Review 4.  Stroke and T-cells.

Authors:  Thiruma V Arumugam; D Neil Granger; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

5.  Induction of granulocyte colony-stimulating factor mRNA by focal cerebral ischemia and cortical spreading depression.

Authors:  Christoph Kleinschnitz; Michael Schroeter; Sebastian Jander; Guido Stoll
Journal:  Brain Res Mol Brain Res       Date:  2004-11-24

6.  Neuroprotective role of microglia expressing interleukin-4.

Authors:  K W Park; D Y Lee; E H Joe; S U Kim; B K Jin
Journal:  J Neurosci Res       Date:  2005-08-01       Impact factor: 4.164

7.  Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179.

Authors:  Christine Krämer; Julia Sunkomat; Jana Witte; Maren Luchtefeld; Michael Walden; Boris Schmidt; Dimitrios Tsikas; Rainer H Böger; Wolf-Georg Forssmann; Helmut Drexler; Bernhard Schieffer
Journal:  Circ Res       Date:  2002-04-19       Impact factor: 17.367

8.  Mitogenic effects of interleukin-5 on microglia.

Authors:  G E Ringheim
Journal:  Neurosci Lett       Date:  1995-12-08       Impact factor: 3.046

9.  Angiotensin AT2 receptor stimulation increases survival in gerbils with abrupt unilateral carotid ligation.

Authors:  L A Fernandez; V J Caride; C Strömberg; L Näveri; J D Wicke
Journal:  J Cardiovasc Pharmacol       Date:  1994-12       Impact factor: 3.105

Review 10.  Peptide receptors in astroglia: focus on angiotensin II and atrial natriuretic peptide.

Authors:  C Sumners; W Tang; W Paulding; M K Raizada
Journal:  Glia       Date:  1994-06       Impact factor: 7.452

View more
  8 in total

Review 1.  Microglia mediated neuroinflammation - signaling regulation and therapeutic considerations with special reference to some natural compounds.

Authors:  Yue-Yi Yao; Eng-Ang Ling; Di Lu
Journal:  Histol Histopathol       Date:  2020-07-14       Impact factor: 2.303

Review 2.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors:  Juan M Saavedra
Journal:  Clin Sci (Lond)       Date:  2012-11       Impact factor: 6.124

3.  Central angiotensin II has catabolic action at white and brown adipose tissue.

Authors:  Annette D de Kloet; Eric G Krause; Karen A Scott; Michelle T Foster; James P Herman; Randall R Sakai; Randy J Seeley; Stephen C Woods
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-23       Impact factor: 4.310

4.  Angiotensin II Type 1a Receptors in the Subfornical Organ Modulate Neuroinflammation in the Hypothalamic Paraventricular Nucleus in Heart Failure Rats.

Authors:  Yang Yu; Shun-Guang Wei; Robert M Weiss; Robert B Felder
Journal:  Neuroscience       Date:  2018-04-21       Impact factor: 3.590

Review 5.  Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

6.  Angiotensin Receptor Blockade by Inhibiting Glial Activation Promotes Hippocampal Neurogenesis Via Activation of Wnt/β-Catenin Signaling in Hypertension.

Authors:  Shahnawaz Ali Bhat; Ruby Goel; Shubha Shukla; Rakesh Shukla; Kashif Hanif
Journal:  Mol Neurobiol       Date:  2017-09-07       Impact factor: 5.590

7.  Electroacupuncture improves cerebral blood flow and attenuates moderate ischemic injury via Angiotensin II its receptors-mediated mechanism in rats.

Authors:  Jing Li; Jiaojun He; Yuanhao Du; Jingjun Cui; Ying Ma; Xuezhu Zhang
Journal:  BMC Complement Altern Med       Date:  2014-11-11       Impact factor: 3.659

8.  Interplay between endothelin and erythropoietin in astroglia: the role in protection against hypoxia.

Authors:  Richard Schäfer; Lars Mueller; Reinhild Buecheler; Barbara Proksch; Matthias Schwab; Christoph H Gleiter; Lusine Danielyan
Journal:  Int J Mol Sci       Date:  2014-02-19       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.